Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
CBAK Energy Technology Ltd
CBAT
$65.5M
| $375K | ﹤0.01% |
350,802
-383,233
| -52% | -$444K |
|
3327
HBT Financial
HBT
$1.35B
| $375K | ﹤0.01% |
21,000
-17,500
| -45% | -$307K |
|
3328
Valens Semiconductor
VLN
$210M
| $375K | ﹤0.01% |
+107,900
| New | +$392K |
|
|
IBDQ
3329
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $373K | ﹤0.01% |
+15,095
| New | +$376K |
|
3330
World Acceptance Corp
WRLD
$875M
| $373K | ﹤0.01% |
+3,325
| New | +$523K |
|
3331
Matrix Service
MTRX
$328M
| $372K | ﹤0.01% |
+73,600
| New | +$461K |
|
|
FINV
3332
FinVolution Group
FINV
$1.07B
| $371K | ﹤0.01% |
78,100
+47,600
| +156% | +$192K |
|
3333
Standard BioTools
LAB
$294M
| $371K | ﹤0.01% |
231,900
+114,400
| +97% | +$283K |
|
|
SOL
3334
DELISTED
Emeren Group
SOL
| $370K | ﹤0.01% |
+77,800
| New | +$379K |
|
|
ARAV
3335
DELISTED
Aravive, Inc. Common Stock
ARAV
| $370K | ﹤0.01% |
374,945
+97,116
| +35% | +$128K |
|
3336
iShares MSCI France ETF
EWQ
$332M
| $369K | ﹤0.01% |
12,300
-25,400
| -67% | -$834K |
|
|
MRIN
3337
DELISTED
Marin Software
MRIN
| $369K | ﹤0.01% |
37,288
+31,685
| +566% | +$405K |
|
|
HZN
3338
DELISTED
Horizon Global Corporation
HZN
| $369K | ﹤0.01% |
226,102
+24,300
| +12% | +$76.6K |
|
3339
Unity Bancorp
UNTY
$620M
| $368K | ﹤0.01% |
13,900
-7,180
| -34% | -$202K |
|
3340
Forum Energy Technologies
FET
$927M
| $367K | ﹤0.01% |
18,700
-343
| -2% | -$7.62K |
|
3341
Excelerate Energy
EE
$1.12B
| $365K | ﹤0.01% |
+18,300
| New | +$464K |
|
|
YARW
3342
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $365K | ﹤0.01% |
1,044
-28
| -3% | -$11.7K |
|
|
OMGA
3343
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $364K | ﹤0.01% |
+95,663
| New | +$356K |
|
|
CONN
3344
DELISTED
Conn's Inc.
CONN
| $363K | ﹤0.01% |
+45,312
| New | +$595K |
|
|
ELEV
3345
DELISTED
Elevation Oncology
ELEV
| $362K | ﹤0.01% |
258,400
+233,000
| +917% | +$585K |
|
|
VIRX
3346
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $362K | ﹤0.01% |
93,399
+45,399
| +95% | +$129K |
|
3347
iShares MSCI Netherlands ETF
EWN
$735M
| $361K | ﹤0.01% |
10,300
-30,400
| -75% | -$1.16M |
|
3348
Hawthorn Bancshares
HWBK
$277M
| $361K | ﹤0.01% |
14,722
-5,585
| -28% | -$136K |
|
3349
MarketWise
MKTW
$53.1M
| $361K | ﹤0.01% |
5,010
+570
| +13% | +$39.6K |
|
3350
American Realty Investors
ARL
$246M
| $360K | ﹤0.01% |
25,399
+3,700
| +17% | +$69.8K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.